Reach Us +44-1647-403003
Editor - Xichun (Mark) Zhou | ADA Technologies | 4456
ISSN: 1948-5956

Journal of Cancer Science & Therapy
Open Access

Like us on:

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.
Relevant Topics

Xichun (Mark) Zhou

Xichun (Mark) Zhou
Xichun (Mark) Zhou, PhD
ADA Technologies
Tel. (303) 874-8273/(303)-717- 4518
Fax (303) 792-5633


Dr. Xichun Zhou received his Ph.D. degree in organic and bioanalytical chemistry at Wuhan University (1994) and had postdoctoral training in the Department of Chemistry, Carmbridge University, UK. He has been a Senior Research Scientist at ADA since 2005, where he leads a program in glycomics and development of biotechnology and biochemical devices. Prior to joining ADA, he was a Research Scientist at Oak Ridge National Laboratory where he led projects on surface chemistries associated with nanoengineered interface of DNA, proteins and carbohydrates for microarray/biochips and biosensor application. Dr. Zhou had a joint appointment with the Graduate School of Genome and Technology at the University of Tennessee during year 2003-2005, where he managed and conducted a project for development of microarray technology. Dr. Zhou has authored twenty peer-reviewed papers, three invited book chapters, and two US Patents in protein microarray and glycomic technology. He has served for NIH study sections in Special Emphasis Panel in 2007.

Research Interest

Cancer Science.



Global Speakers in the subject

Global Experts in the subject